If you or a loved one is struggling with opioid use disorder, we can help. At Community Medical Services, we understand the challenges of addiction and are here to support you every step of the way. Brixadi is a trusted, FDA-approved medication that can provide immediate relief from withdrawal symptoms and help you stay on track. Our compassionate team provides personalized, medication-assisted treatment to help you achieve long-term recovery and reclaim your life.
Brixadi is an extended-release form of buprenorphine that is injected once a month to treat individuals suffering from moderate to severe opioid use disorder (OUD). After receiving FDA approval in 2023, Brixadi has become an effective alternative to other single-dose buprenorphine treatments.
Like Suboxone and Sublocade, Brixadi reduces withdrawal symptoms, the likelihood of relapse, and the cravings associated with OUD. With a wide range of dosing options available, Brixadi can be tailored to meet each patient’s unique needs.
Brixadi is a buprenorphine medication, making it a partial opioid agonist. It binds to the same neuroreceptors in the brain as illicit opioids, blocking the pathways to prevent the abused opioids from targeting them. This provides relief from withdrawal symptoms and cravings without the euphoric effects of illicit opioids.
Like other MAT methods, Brixadi treatment is most effective when paired with a comprehensive plan that includes counseling and therapy services to address the underlying causes of opioid dependence. Community Medical Services works with patients to create a comprehensive treatment plan that treats the “whole patient,” addressing both the physical aspects of addiction and its underlying causes to facilitate a complete recovery.
As with all medications, side effects can occur while using Brixadi. However, these are uncommon and often clear up in a few days. While there is a chance of nausea, headache, trouble sleeping, or constipation, patients using Brixadi don’t typically notice severe or long-lasting symptoms.
With medication-assisted treatment, patients receive a comprehensive, tailored treatment plan that addresses all aspects of their addiction. Like other MAT options, Brixadi is an effective way to help patients remain in treatment and avoid relapse. The primary benefits of Brixadi treatment include:
Brixadi can be administered weekly or monthly, allowing patients to adjust treatment to suit their unique needs and taper the medication as treatment progresses
For patients who may struggle with higher doses of injectable buprenorphine, Brixadi offers various strengths to help patients of all tolerance levels receive treatment.
Brixadi injections are effective from multiple recommended injection sites, whether through the buttock, thigh, abdomen, or upper arm.
Brixadi is available in multiple strengths and is administered weekly or monthly. Because it works the same way as other buprenorphine injection treatments, patients who are already in treatment with other forms of buprenorphine can easily switch to Brixadi. A healthcare professional administers both weekly and monthly Brixadi injections in a clinical setting.
Weekly Dose Strengths: 8mg (0.16mL), 16mg (0.32mL), 24mg (0.48mL), and 32mg (0.64mL).
Monthly Dose Strengths: 64mg (0.18mL), 96mg (0.27mL), and 128mg (0.36mL).
Brixadi medication-assisted treatment is a powerful tool for reducing withdrawal symptoms and cravings to help patients stay committed to their treatment plans. However, it may not be the best choice for all patients. At Community Medical Services, we believe in a personalized approach to medication-assisted treatment. We encourage you to discuss your unique situation and needs with our CMS professionals, who will help you explore all available options and find the best treatment plan for your journey to recovery.
Please read this Privacy Policy carefully because it has disclaimers of warranties and releases of liability.
This website uses cookies to deliver a better user experience